The Guardian investigation revealed that the firm floated to achieve this target, Biovaccines Nigeria Limited, has yet to complete building the state-of-the-art pharmaceutical manufacturing facility needed for the vaccines. The Federal Government had in 2017 inaugurated an initiative to begin local production of essential vaccines. Agwale said Innovative Biotech will manufacture vaccines in Nigeria, and the vaccines will be sold on the continent for local consumption. Adeyeye, who is also a pharmacist, said Nigeria is upbeat about manufacturing of local vaccines because NAFDAC had achieved Maturity Level 3. Regarding the production of the vaccines, Adeyeye said: “Yes, we are working on local manufacture of vaccines.

Source: The Guardian April 29, 2022 04:46 UTC